Russell Investments Group
REGN icon

Russell Investments Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$91.1M Buy
173,809
+27,069
+18% +$14.2M 0.12% 183
2025
Q1
$93.1M Buy
146,740
+9,532
+7% +$6.05M 0.13% 167
2024
Q4
$97.7M Buy
137,208
+7,944
+6% +$5.66M 0.13% 151
2024
Q3
$136M Buy
129,264
+2,516
+2% +$2.64M 0.2% 94
2024
Q2
$133M Sell
126,748
-1,763
-1% -$1.85M 0.21% 85
2024
Q1
$124M Buy
128,511
+7,481
+6% +$7.2M 0.2% 102
2023
Q4
$106M Sell
121,030
-5,171
-4% -$4.54M 0.19% 108
2023
Q3
$104M Buy
126,201
+352
+0.3% +$290K 0.21% 92
2023
Q2
$90.4M Sell
125,849
-2,653
-2% -$1.9M 0.17% 118
2023
Q1
$105M Sell
128,502
-6,275
-5% -$5.15M 0.21% 101
2022
Q4
$97.2M Sell
134,777
-32,205
-19% -$23.2M 0.2% 105
2022
Q3
$115M Buy
166,982
+6,369
+4% +$4.39M 0.25% 71
2022
Q2
$95.2M Sell
160,613
-26,577
-14% -$15.7M 0.19% 115
2022
Q1
$131M Sell
187,190
-24,865
-12% -$17.3M 0.23% 85
2021
Q4
$134M Buy
212,055
+6,112
+3% +$3.87M 0.21% 91
2021
Q3
$125M Buy
205,943
+17,105
+9% +$10.4M 0.21% 95
2021
Q2
$105M Buy
188,838
+24,724
+15% +$13.7M 0.18% 114
2021
Q1
$77.5M Buy
164,114
+33,307
+25% +$15.7M 0.14% 159
2020
Q4
$63.1M Buy
130,807
+3,964
+3% +$1.91M 0.12% 184
2020
Q3
$71.4M Sell
126,843
-9,649
-7% -$5.43M 0.15% 143
2020
Q2
$84.8M Buy
136,492
+16,325
+14% +$10.1M 0.19% 111
2020
Q1
$58.6M Buy
120,167
+6,783
+6% +$3.31M 0.15% 138
2019
Q4
$42.6M Sell
113,384
-45,670
-29% -$17.1M 0.08% 293
2019
Q3
$44.1M Buy
159,054
+61,276
+63% +$17M 0.09% 287
2019
Q2
$30.6M Sell
97,778
-20,747
-18% -$6.49M 0.06% 397
2019
Q1
$48.6M Buy
118,525
+28,802
+32% +$11.8M 0.09% 263
2018
Q4
$33.4M Sell
89,723
-16,945
-16% -$6.31M 0.07% 299
2018
Q3
$43.1M Buy
106,668
+18,742
+21% +$7.57M 0.08% 264
2018
Q2
$30.3M Sell
87,926
-95,630
-52% -$33M 0.06% 353
2018
Q1
$62.8M Buy
183,556
+14,776
+9% +$5.06M 0.11% 224
2017
Q4
$64.6M Buy
168,780
+4,084
+2% +$1.56M 0.11% 210
2017
Q3
$73.6M Buy
164,696
+18,443
+13% +$8.24M 0.13% 184
2017
Q2
$71.9M Sell
146,253
-8,844
-6% -$4.35M 0.13% 180
2017
Q1
$60.1M Buy
155,097
+13,539
+10% +$5.25M 0.11% 214
2016
Q4
$52.9M Buy
+141,558
New +$52.9M 0.1% 220